CSM Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
CSM Advisors's JAZZ Position: Q3 2026 in Review
CSM Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 30% in Q3 2026, selling an estimated $336K and leaving 3,209 shares worth $744K. The position accounts for 0.02% of the portfolio, ranked #349.
CSM Advisors first reported a position in JAZZ in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.1M in Q2 2026. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- CSM Advisors held 3,209 shares of Jazz Pharmaceuticals worth $744K as of Q3 2026.
- CSM Advisors sold 1,359 Jazz Pharmaceuticals shares in Q3 2026, an estimated $336K.
- Jazz Pharmaceuticals made up 0.02% of CSM Advisors's portfolio in Q3 2026, its #349 holding.
- CSM Advisors first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- CSM Advisors's Jazz Pharmaceuticals position peaked at $1.1M in Q2 2026.
- 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on CSM Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.